Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 359.00 USD | +0.38% |
|
+1.50% | +30.48% |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 25,267 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 27.65% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 24,759 | 24,526 | 24,305 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 28.91% | -0.94% | -0.9% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 42.5x | 37.2x | 33.5x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.08x | 7.13x | 6.27x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.8x | 2.6x | 3x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.58x | 7.14x | 6.66x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.43x | 6.93x | 6.41x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 26.8x | 24.1x | 21.5x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 33.4x | 29.8x | 26.4x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 53.9x | 45.5x | 37.5x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.85% | 2.2% | 2.66% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.8774 | 0.9571 | 1.094 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.25% | 0.27% | 0.31% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.416 | 9.619 | 10.68 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.4% | 9.95% | 10.2% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,333 | 3,537 | 3,792 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 923.3 | 1,017 | 1,129 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 741.1 | 823.5 | 922 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 604.2 | 685.6 | 754.9 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -508.1 | -741.3 | -961.7 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 357.65 | 357.65 | 357.65 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,648 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 42.5x | 7.43x | 26.82x | 0.25% | 25.27B | ||
| 22x | 3.32x | 12.36x | 2.86% | 155B | ||
| 17.99x | 3.16x | 11.14x | 3.74% | 102B | ||
| 16.81x | 0.19x | 11.89x | 0.78% | 58.81B | ||
| 32.32x | 7.84x | 20.51x | 1.24% | 52.82B | ||
| 37.54x | 2.99x | 10.27x | 2.56% | 41.51B | ||
| 37.06x | 1.36x | 11.95x | 0.21% | 32.69B | ||
| 30.28x | 5.4x | 17.21x | -.--% | 28.6B | ||
| 22.96x | 3.36x | 12.09x | 1.26% | 20.34B | ||
| 47.92x | 6.43x | 20.66x | 0.45% | 20.99B | ||
| Average | 30.74x | 4.15x | 15.49x | 1.34% | 53.75B | |
| Weighted average by Cap. | 26.26x | 3.67x | 13.94x | 2.03% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















